학술논문

Safety and efficacy of tazemetostat, an enhancer of zeste-homolog 2 inhibitor, in patients with relapsed or refractory malignant mesothelioma.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2020, 38 15, 2p. Supplement: S
Subject
Language
English
ISSN
15277755